Overcoming challenges associated with identifying FBN1 deep intronic variants through whole‐genome sequencing

Background Marfan syndrome (MFS), caused by pathogenic variants of FBN1 (fibrillin‐1), is a systemic connective tissue disorder with variable phenotypes and treatment responsiveness depending on the variant. However, a significant number of individuals with MFS remain genetically unexplained. In thi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical laboratory analysis 2024-01, Vol.38 (1-2), p.e25009-n/a
Hauptverfasser: Kim, Jee Ah, Jang, Mi‐Ae, Jang, Shin Yi, Kim, Duk‐Kyung, Kim, Young‐gon, Kim, Jong‐Won, Park, Taek Kyu, Jang, Ja‐Hyun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 1-2
container_start_page e25009
container_title Journal of clinical laboratory analysis
container_volume 38
creator Kim, Jee Ah
Jang, Mi‐Ae
Jang, Shin Yi
Kim, Duk‐Kyung
Kim, Young‐gon
Kim, Jong‐Won
Park, Taek Kyu
Jang, Ja‐Hyun
description Background Marfan syndrome (MFS), caused by pathogenic variants of FBN1 (fibrillin‐1), is a systemic connective tissue disorder with variable phenotypes and treatment responsiveness depending on the variant. However, a significant number of individuals with MFS remain genetically unexplained. In this study, we report novel pathogenic intronic variants in FBN1 in two unrelated families with MFS. Methods We evaluated subjects with suspected MFS from two unrelated families using Sanger sequencing or multiplex ligation‐dependent probe amplification of FBN1 and/or panel‐based next‐generation sequencing. As no pathogenic variants were identified, whole‐genome sequencing was performed. Identified variants were analyzed by reverse transcription‐PCR and targeted sequencing of FBN1 mRNA harvested from peripheral blood or skin fibroblasts obtained from affected probands. Results We found causative deep intronic variants, c.6163+1484A>T and c.5788+36C>A, in FBN1. The splicing analysis revealed an insertion of in‐frame or out‐of‐frame intronic sequences of the FBN1 transcript predicted to alter function of calcium‐binding epidermal growth factor protein domain. Family members carrying c.6163+1484A>T had high systemic scores including prominent skeletal features and aortic dissection with lesser aortic dilatation. Family members carrying c.5788+36C>A had more severe aortic root dilatation without aortic dissection. Both families had ectopia lentis. Conclusion Variable penetrance of the phenotype and negative genetic testing in MFS families should raise the possibility of deep intronic FBN1 variants and the need for additional molecular studies. This study expands the mutation spectrum of FBN1 and points out the importance of intronic sequence analysis and the need for integrative functional studies in MFS diagnosis. We report two novel intronic variants of FBN1 (c.6163+1484A>T and c.5788+36C>A) associated with Marfan syndrome in two unrelated families. Reverse transcription‐PCR and targeted sequencing revealed retention of in‐frame or out‐of‐frame intronic sequences in the FBN1 transcript. This study points out the importance of intronic sequence analysis and the need for integrative functional studies in Marfan syndrome diagnosis.
doi_str_mv 10.1002/jcla.25009
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10829686</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2916405197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4089-79b02950929ba69124056b279fcf7cc478117652cb097ba0c6fd6afe55cbd533</originalsourceid><addsrcrecordid>eNp9kc1u1DAURi0EokNhwwMgS2wQUsq1M0nsFSqjlh-N6KZ7y3FuEo8Se7CTGc2OR-AZ-yR4mFIBC1Ze5OTo2B8hLxlcMAD-bmMGfcELAPmILBhIkXHBi8dkAUJUmQCWn5FnMW4AQEhWPiVnueD5EkS1IP5mh8H40bqOml4PA7oOI9UxemP1hA3d26mntkE32fZwxK4_fGW0QdxS66bgnTV0p4PVbop06oOfu57uez_g3fcfHTo_Io34bUZn0t_PyZNWDxFf3J_n5Pb66nb1KVvffPy8ulxnJnXJrJI1cFmA5LLWpWR8CUVZ80q2pq2MWVaCsaosuKlBVrUGU7ZNqVssClM3RZ6fk_cn7XauR2xMqg96UNtgRx0Oymur_v7ibK86v1MMBJelKJPhzb0h-BQfJzXaaHAYtEM_R8XTS6YoJquEvv4H3fg5uHS9RHFgIk_GRL09USb4GAO2DzUM1HFHddxR_doxwa_-7H9Afw-XAHYC9nbAw39U6stqfXmS_gRx1atG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2920183968</pqid></control><display><type>article</type><title>Overcoming challenges associated with identifying FBN1 deep intronic variants through whole‐genome sequencing</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley-Blackwell Open Access Titles</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library All Journals</source><source>PubMed Central</source><creator>Kim, Jee Ah ; Jang, Mi‐Ae ; Jang, Shin Yi ; Kim, Duk‐Kyung ; Kim, Young‐gon ; Kim, Jong‐Won ; Park, Taek Kyu ; Jang, Ja‐Hyun</creator><creatorcontrib>Kim, Jee Ah ; Jang, Mi‐Ae ; Jang, Shin Yi ; Kim, Duk‐Kyung ; Kim, Young‐gon ; Kim, Jong‐Won ; Park, Taek Kyu ; Jang, Ja‐Hyun</creatorcontrib><description>Background Marfan syndrome (MFS), caused by pathogenic variants of FBN1 (fibrillin‐1), is a systemic connective tissue disorder with variable phenotypes and treatment responsiveness depending on the variant. However, a significant number of individuals with MFS remain genetically unexplained. In this study, we report novel pathogenic intronic variants in FBN1 in two unrelated families with MFS. Methods We evaluated subjects with suspected MFS from two unrelated families using Sanger sequencing or multiplex ligation‐dependent probe amplification of FBN1 and/or panel‐based next‐generation sequencing. As no pathogenic variants were identified, whole‐genome sequencing was performed. Identified variants were analyzed by reverse transcription‐PCR and targeted sequencing of FBN1 mRNA harvested from peripheral blood or skin fibroblasts obtained from affected probands. Results We found causative deep intronic variants, c.6163+1484A&gt;T and c.5788+36C&gt;A, in FBN1. The splicing analysis revealed an insertion of in‐frame or out‐of‐frame intronic sequences of the FBN1 transcript predicted to alter function of calcium‐binding epidermal growth factor protein domain. Family members carrying c.6163+1484A&gt;T had high systemic scores including prominent skeletal features and aortic dissection with lesser aortic dilatation. Family members carrying c.5788+36C&gt;A had more severe aortic root dilatation without aortic dissection. Both families had ectopia lentis. Conclusion Variable penetrance of the phenotype and negative genetic testing in MFS families should raise the possibility of deep intronic FBN1 variants and the need for additional molecular studies. This study expands the mutation spectrum of FBN1 and points out the importance of intronic sequence analysis and the need for integrative functional studies in MFS diagnosis. We report two novel intronic variants of FBN1 (c.6163+1484A&gt;T and c.5788+36C&gt;A) associated with Marfan syndrome in two unrelated families. Reverse transcription‐PCR and targeted sequencing revealed retention of in‐frame or out‐of‐frame intronic sequences in the FBN1 transcript. This study points out the importance of intronic sequence analysis and the need for integrative functional studies in Marfan syndrome diagnosis.</description><identifier>ISSN: 0887-8013</identifier><identifier>ISSN: 1098-2825</identifier><identifier>EISSN: 1098-2825</identifier><identifier>DOI: 10.1002/jcla.25009</identifier><identifier>PMID: 38234087</identifier><language>eng</language><publisher>United States: John Wiley &amp; Sons, Inc</publisher><subject>Adipokines - genetics ; Aneurysms ; Aorta ; Aortic Diseases ; Aortic Dissection ; Bone diseases ; Connective tissue diseases ; Coronary vessels ; Dissection ; Ectopia ; FBN1 ; Fibrillin ; Fibrillin-1 - genetics ; Genes ; Genetic screening ; Genetic Testing ; Genomes ; Genomics ; Height ; Humans ; Liver cancer ; Marfan syndrome ; Marfan Syndrome - complications ; Marfan Syndrome - diagnosis ; Marfan Syndrome - genetics ; messenger RNA ; Mutation - genetics ; Next-generation sequencing ; Peripheral blood ; phenotype ; Phenotypes ; Reverse transcription ; Skin ; Software ; Standard scores ; Surgery ; Whole genome sequencing</subject><ispartof>Journal of clinical laboratory analysis, 2024-01, Vol.38 (1-2), p.e25009-n/a</ispartof><rights>2024 The Authors. published by Wiley Periodicals LLC.</rights><rights>2024 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.</rights><rights>2024. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4089-79b02950929ba69124056b279fcf7cc478117652cb097ba0c6fd6afe55cbd533</cites><orcidid>0000-0002-7011-1537 ; 0000-0002-0708-9242 ; 0000-0003-4319-7029 ; 0000-0003-1440-3583 ; 0000-0001-6840-6830 ; 0000-0002-6558-5236 ; 0000-0003-0516-4947 ; 0000-0002-2348-8948</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10829686/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10829686/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1417,11562,27924,27925,45574,45575,46052,46476,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38234087$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Jee Ah</creatorcontrib><creatorcontrib>Jang, Mi‐Ae</creatorcontrib><creatorcontrib>Jang, Shin Yi</creatorcontrib><creatorcontrib>Kim, Duk‐Kyung</creatorcontrib><creatorcontrib>Kim, Young‐gon</creatorcontrib><creatorcontrib>Kim, Jong‐Won</creatorcontrib><creatorcontrib>Park, Taek Kyu</creatorcontrib><creatorcontrib>Jang, Ja‐Hyun</creatorcontrib><title>Overcoming challenges associated with identifying FBN1 deep intronic variants through whole‐genome sequencing</title><title>Journal of clinical laboratory analysis</title><addtitle>J Clin Lab Anal</addtitle><description>Background Marfan syndrome (MFS), caused by pathogenic variants of FBN1 (fibrillin‐1), is a systemic connective tissue disorder with variable phenotypes and treatment responsiveness depending on the variant. However, a significant number of individuals with MFS remain genetically unexplained. In this study, we report novel pathogenic intronic variants in FBN1 in two unrelated families with MFS. Methods We evaluated subjects with suspected MFS from two unrelated families using Sanger sequencing or multiplex ligation‐dependent probe amplification of FBN1 and/or panel‐based next‐generation sequencing. As no pathogenic variants were identified, whole‐genome sequencing was performed. Identified variants were analyzed by reverse transcription‐PCR and targeted sequencing of FBN1 mRNA harvested from peripheral blood or skin fibroblasts obtained from affected probands. Results We found causative deep intronic variants, c.6163+1484A&gt;T and c.5788+36C&gt;A, in FBN1. The splicing analysis revealed an insertion of in‐frame or out‐of‐frame intronic sequences of the FBN1 transcript predicted to alter function of calcium‐binding epidermal growth factor protein domain. Family members carrying c.6163+1484A&gt;T had high systemic scores including prominent skeletal features and aortic dissection with lesser aortic dilatation. Family members carrying c.5788+36C&gt;A had more severe aortic root dilatation without aortic dissection. Both families had ectopia lentis. Conclusion Variable penetrance of the phenotype and negative genetic testing in MFS families should raise the possibility of deep intronic FBN1 variants and the need for additional molecular studies. This study expands the mutation spectrum of FBN1 and points out the importance of intronic sequence analysis and the need for integrative functional studies in MFS diagnosis. We report two novel intronic variants of FBN1 (c.6163+1484A&gt;T and c.5788+36C&gt;A) associated with Marfan syndrome in two unrelated families. Reverse transcription‐PCR and targeted sequencing revealed retention of in‐frame or out‐of‐frame intronic sequences in the FBN1 transcript. This study points out the importance of intronic sequence analysis and the need for integrative functional studies in Marfan syndrome diagnosis.</description><subject>Adipokines - genetics</subject><subject>Aneurysms</subject><subject>Aorta</subject><subject>Aortic Diseases</subject><subject>Aortic Dissection</subject><subject>Bone diseases</subject><subject>Connective tissue diseases</subject><subject>Coronary vessels</subject><subject>Dissection</subject><subject>Ectopia</subject><subject>FBN1</subject><subject>Fibrillin</subject><subject>Fibrillin-1 - genetics</subject><subject>Genes</subject><subject>Genetic screening</subject><subject>Genetic Testing</subject><subject>Genomes</subject><subject>Genomics</subject><subject>Height</subject><subject>Humans</subject><subject>Liver cancer</subject><subject>Marfan syndrome</subject><subject>Marfan Syndrome - complications</subject><subject>Marfan Syndrome - diagnosis</subject><subject>Marfan Syndrome - genetics</subject><subject>messenger RNA</subject><subject>Mutation - genetics</subject><subject>Next-generation sequencing</subject><subject>Peripheral blood</subject><subject>phenotype</subject><subject>Phenotypes</subject><subject>Reverse transcription</subject><subject>Skin</subject><subject>Software</subject><subject>Standard scores</subject><subject>Surgery</subject><subject>Whole genome sequencing</subject><issn>0887-8013</issn><issn>1098-2825</issn><issn>1098-2825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kc1u1DAURi0EokNhwwMgS2wQUsq1M0nsFSqjlh-N6KZ7y3FuEo8Se7CTGc2OR-AZ-yR4mFIBC1Ze5OTo2B8hLxlcMAD-bmMGfcELAPmILBhIkXHBi8dkAUJUmQCWn5FnMW4AQEhWPiVnueD5EkS1IP5mh8H40bqOml4PA7oOI9UxemP1hA3d26mntkE32fZwxK4_fGW0QdxS66bgnTV0p4PVbop06oOfu57uez_g3fcfHTo_Io34bUZn0t_PyZNWDxFf3J_n5Pb66nb1KVvffPy8ulxnJnXJrJI1cFmA5LLWpWR8CUVZ80q2pq2MWVaCsaosuKlBVrUGU7ZNqVssClM3RZ6fk_cn7XauR2xMqg96UNtgRx0Oymur_v7ibK86v1MMBJelKJPhzb0h-BQfJzXaaHAYtEM_R8XTS6YoJquEvv4H3fg5uHS9RHFgIk_GRL09USb4GAO2DzUM1HFHddxR_doxwa_-7H9Afw-XAHYC9nbAw39U6stqfXmS_gRx1atG</recordid><startdate>202401</startdate><enddate>202401</enddate><creator>Kim, Jee Ah</creator><creator>Jang, Mi‐Ae</creator><creator>Jang, Shin Yi</creator><creator>Kim, Duk‐Kyung</creator><creator>Kim, Young‐gon</creator><creator>Kim, Jong‐Won</creator><creator>Park, Taek Kyu</creator><creator>Jang, Ja‐Hyun</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7011-1537</orcidid><orcidid>https://orcid.org/0000-0002-0708-9242</orcidid><orcidid>https://orcid.org/0000-0003-4319-7029</orcidid><orcidid>https://orcid.org/0000-0003-1440-3583</orcidid><orcidid>https://orcid.org/0000-0001-6840-6830</orcidid><orcidid>https://orcid.org/0000-0002-6558-5236</orcidid><orcidid>https://orcid.org/0000-0003-0516-4947</orcidid><orcidid>https://orcid.org/0000-0002-2348-8948</orcidid></search><sort><creationdate>202401</creationdate><title>Overcoming challenges associated with identifying FBN1 deep intronic variants through whole‐genome sequencing</title><author>Kim, Jee Ah ; Jang, Mi‐Ae ; Jang, Shin Yi ; Kim, Duk‐Kyung ; Kim, Young‐gon ; Kim, Jong‐Won ; Park, Taek Kyu ; Jang, Ja‐Hyun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4089-79b02950929ba69124056b279fcf7cc478117652cb097ba0c6fd6afe55cbd533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adipokines - genetics</topic><topic>Aneurysms</topic><topic>Aorta</topic><topic>Aortic Diseases</topic><topic>Aortic Dissection</topic><topic>Bone diseases</topic><topic>Connective tissue diseases</topic><topic>Coronary vessels</topic><topic>Dissection</topic><topic>Ectopia</topic><topic>FBN1</topic><topic>Fibrillin</topic><topic>Fibrillin-1 - genetics</topic><topic>Genes</topic><topic>Genetic screening</topic><topic>Genetic Testing</topic><topic>Genomes</topic><topic>Genomics</topic><topic>Height</topic><topic>Humans</topic><topic>Liver cancer</topic><topic>Marfan syndrome</topic><topic>Marfan Syndrome - complications</topic><topic>Marfan Syndrome - diagnosis</topic><topic>Marfan Syndrome - genetics</topic><topic>messenger RNA</topic><topic>Mutation - genetics</topic><topic>Next-generation sequencing</topic><topic>Peripheral blood</topic><topic>phenotype</topic><topic>Phenotypes</topic><topic>Reverse transcription</topic><topic>Skin</topic><topic>Software</topic><topic>Standard scores</topic><topic>Surgery</topic><topic>Whole genome sequencing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Jee Ah</creatorcontrib><creatorcontrib>Jang, Mi‐Ae</creatorcontrib><creatorcontrib>Jang, Shin Yi</creatorcontrib><creatorcontrib>Kim, Duk‐Kyung</creatorcontrib><creatorcontrib>Kim, Young‐gon</creatorcontrib><creatorcontrib>Kim, Jong‐Won</creatorcontrib><creatorcontrib>Park, Taek Kyu</creatorcontrib><creatorcontrib>Jang, Ja‐Hyun</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>Wiley Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical laboratory analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Jee Ah</au><au>Jang, Mi‐Ae</au><au>Jang, Shin Yi</au><au>Kim, Duk‐Kyung</au><au>Kim, Young‐gon</au><au>Kim, Jong‐Won</au><au>Park, Taek Kyu</au><au>Jang, Ja‐Hyun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Overcoming challenges associated with identifying FBN1 deep intronic variants through whole‐genome sequencing</atitle><jtitle>Journal of clinical laboratory analysis</jtitle><addtitle>J Clin Lab Anal</addtitle><date>2024-01</date><risdate>2024</risdate><volume>38</volume><issue>1-2</issue><spage>e25009</spage><epage>n/a</epage><pages>e25009-n/a</pages><issn>0887-8013</issn><issn>1098-2825</issn><eissn>1098-2825</eissn><abstract>Background Marfan syndrome (MFS), caused by pathogenic variants of FBN1 (fibrillin‐1), is a systemic connective tissue disorder with variable phenotypes and treatment responsiveness depending on the variant. However, a significant number of individuals with MFS remain genetically unexplained. In this study, we report novel pathogenic intronic variants in FBN1 in two unrelated families with MFS. Methods We evaluated subjects with suspected MFS from two unrelated families using Sanger sequencing or multiplex ligation‐dependent probe amplification of FBN1 and/or panel‐based next‐generation sequencing. As no pathogenic variants were identified, whole‐genome sequencing was performed. Identified variants were analyzed by reverse transcription‐PCR and targeted sequencing of FBN1 mRNA harvested from peripheral blood or skin fibroblasts obtained from affected probands. Results We found causative deep intronic variants, c.6163+1484A&gt;T and c.5788+36C&gt;A, in FBN1. The splicing analysis revealed an insertion of in‐frame or out‐of‐frame intronic sequences of the FBN1 transcript predicted to alter function of calcium‐binding epidermal growth factor protein domain. Family members carrying c.6163+1484A&gt;T had high systemic scores including prominent skeletal features and aortic dissection with lesser aortic dilatation. Family members carrying c.5788+36C&gt;A had more severe aortic root dilatation without aortic dissection. Both families had ectopia lentis. Conclusion Variable penetrance of the phenotype and negative genetic testing in MFS families should raise the possibility of deep intronic FBN1 variants and the need for additional molecular studies. This study expands the mutation spectrum of FBN1 and points out the importance of intronic sequence analysis and the need for integrative functional studies in MFS diagnosis. We report two novel intronic variants of FBN1 (c.6163+1484A&gt;T and c.5788+36C&gt;A) associated with Marfan syndrome in two unrelated families. Reverse transcription‐PCR and targeted sequencing revealed retention of in‐frame or out‐of‐frame intronic sequences in the FBN1 transcript. This study points out the importance of intronic sequence analysis and the need for integrative functional studies in Marfan syndrome diagnosis.</abstract><cop>United States</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>38234087</pmid><doi>10.1002/jcla.25009</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-7011-1537</orcidid><orcidid>https://orcid.org/0000-0002-0708-9242</orcidid><orcidid>https://orcid.org/0000-0003-4319-7029</orcidid><orcidid>https://orcid.org/0000-0003-1440-3583</orcidid><orcidid>https://orcid.org/0000-0001-6840-6830</orcidid><orcidid>https://orcid.org/0000-0002-6558-5236</orcidid><orcidid>https://orcid.org/0000-0003-0516-4947</orcidid><orcidid>https://orcid.org/0000-0002-2348-8948</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0887-8013
ispartof Journal of clinical laboratory analysis, 2024-01, Vol.38 (1-2), p.e25009-n/a
issn 0887-8013
1098-2825
1098-2825
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10829686
source MEDLINE; DOAJ Directory of Open Access Journals; Wiley-Blackwell Open Access Titles; EZB-FREE-00999 freely available EZB journals; Wiley Online Library All Journals; PubMed Central
subjects Adipokines - genetics
Aneurysms
Aorta
Aortic Diseases
Aortic Dissection
Bone diseases
Connective tissue diseases
Coronary vessels
Dissection
Ectopia
FBN1
Fibrillin
Fibrillin-1 - genetics
Genes
Genetic screening
Genetic Testing
Genomes
Genomics
Height
Humans
Liver cancer
Marfan syndrome
Marfan Syndrome - complications
Marfan Syndrome - diagnosis
Marfan Syndrome - genetics
messenger RNA
Mutation - genetics
Next-generation sequencing
Peripheral blood
phenotype
Phenotypes
Reverse transcription
Skin
Software
Standard scores
Surgery
Whole genome sequencing
title Overcoming challenges associated with identifying FBN1 deep intronic variants through whole‐genome sequencing
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T02%3A26%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Overcoming%20challenges%20associated%20with%20identifying%20FBN1%20deep%20intronic%20variants%20through%20whole%E2%80%90genome%20sequencing&rft.jtitle=Journal%20of%20clinical%20laboratory%20analysis&rft.au=Kim,%20Jee%20Ah&rft.date=2024-01&rft.volume=38&rft.issue=1-2&rft.spage=e25009&rft.epage=n/a&rft.pages=e25009-n/a&rft.issn=0887-8013&rft.eissn=1098-2825&rft_id=info:doi/10.1002/jcla.25009&rft_dat=%3Cproquest_pubme%3E2916405197%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2920183968&rft_id=info:pmid/38234087&rfr_iscdi=true